PT  - JOURNAL ARTICLE
AU  - Maramattom, Boby Varkey
TI  - Screening power of STIR muscle MRI in Critical illness myo-neuropathy and GBS in the ICU
AID  - 10.1101/2021.07.07.21259996
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.07.21259996
4099  - http://medrxiv.org/content/early/2021/07/09/2021.07.07.21259996.short
4100  - http://medrxiv.org/content/early/2021/07/09/2021.07.07.21259996.full
AB  - Introduction Critical illness myo-neuropathy [CIMN] or ICU acquired weakness [CIMN] is a common cause of weakness in ICU patients. It is diagnosed by clinical features, nerve conduction studies and muscle/nerve biopsies.Methods The MRI muscle STIR images of 7 patients with suspected CIMN and 7 GBS patients were reviewed.Results All 7 patients with CIMN showed diffuse muscle edema, predominating in the lower limbs. Only one patient with GBS showed abnormal MRI changes (14%) and MRI was normal in 86%. The sensitivity of MRI to detect CIMN was 100%, whereas the specificity was 85.7%. Thus, the positive predictive value of MRI in this situation was 87.5% and the negative predictive value was 100%.Conclusions Muscle STIR imaging may help to differentiate between CIMN and GBS and can modify the diagnostic algorithm of CIMN.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee approval; Aster Medcity Ethics committee 2020; approvedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available on request